Your browser doesn't support javascript.
loading
Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma.
Haas, Naomi B; Appleman, Leonard J; Stein, Mark; Redlinger, Maryann; Wilks, Melissa; Xu, Xiaowei; Onorati, Angelique; Kalavacharla, Anusha; Kim, Taehyong; Zhen, Chao Jie; Kadri, Sabah; Segal, Jeremy P; Gimotty, Phyllis A; Davis, Lisa E; Amaravadi, Ravi K.
Afiliación
  • Haas NB; Abramson Cancer Center and the Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania. naomi.haas@uphs.upenn.edu.
  • Appleman LJ; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Stein M; Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
  • Redlinger M; Abramson Cancer Center and the Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Wilks M; Abramson Cancer Center and the Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Xu X; Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Onorati A; Abramson Cancer Center and the Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Kalavacharla A; Abramson Cancer Center and the Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Kim T; Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Zhen CJ; Department of Pathology, University of Chicago, Chicago, Illinois.
  • Kadri S; Department of Pathology, University of Chicago, Chicago, Illinois.
  • Segal JP; Department of Pathology, University of Chicago, Chicago, Illinois.
  • Gimotty PA; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Davis LE; Department of Pharmacy Practice & Science, University of Arizona College of Pharmacy, Tucson, Arizona.
  • Amaravadi RK; Abramson Cancer Center and the Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania.
Clin Cancer Res ; 25(7): 2080-2087, 2019 04 01.
Article en En | MEDLINE | ID: mdl-30635337
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Autofagia / Carcinoma de Células Renales / Serina-Treonina Quinasas TOR / Neoplasias Renales Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Autofagia / Carcinoma de Células Renales / Serina-Treonina Quinasas TOR / Neoplasias Renales Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article